Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitop...
Saved in:
Published in | Vaccines (Basel) Vol. 13; no. 2; p. 140 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
28.01.2025
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusion: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. |
---|---|
AbstractList | Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays.
IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function.
The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12-14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth.
These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12-14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies.Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12-14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusion: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies. |
Audience | Academic |
Author | Kakeya, Hiroshi Nitahara, Yuko Yamamoto, Takuya Kido, Yasutoshi Kase, Tetsuo Nakagama, Yu Masuta, Yuji Matsuura, Tomoka Takahashi, Yoshimasa Fukushima, Wakaba Kondo, Kyoko Kaku, Natsuko Ohfuji, Satoko Nishiyama, Ayae Nogimori, Takuto Nakagama, Sachie |
AuthorAffiliation | 5 Department of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan 1 Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan; anishiyama@nibiohn.go.jp (A.N.); tnogimori@nibiohn.go.jp (T.N.); y-masuta@nibiohn.go.jp (Y.M.) 6 Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan; ytakahas@niid.go.jp 9 Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan 8 Osaka International Research Center for Infectious Diseases, Osaka Metropolitan University, Osaka 545-0051, Japan 2 Department of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan; h21594d@omu.ac.jp (T.M.); kasetetsuo@omu.ac.jp (T.K.); satoko@omu.ac.jp (S.O.); wakaba@omu.ac.jp (W.F.) 3 R |
AuthorAffiliation_xml | – name: 2 Department of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan; h21594d@omu.ac.jp (T.M.); kasetetsuo@omu.ac.jp (T.K.); satoko@omu.ac.jp (S.O.); wakaba@omu.ac.jp (W.F.) – name: 5 Department of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan – name: 6 Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan; ytakahas@niid.go.jp – name: 7 Department of Infection Control Science, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan – name: 10 Department of Virology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan – name: 8 Osaka International Research Center for Infectious Diseases, Osaka Metropolitan University, Osaka 545-0051, Japan – name: 1 Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan; anishiyama@nibiohn.go.jp (A.N.); tnogimori@nibiohn.go.jp (T.N.); y-masuta@nibiohn.go.jp (Y.M.) – name: 9 Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan – name: 3 Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan; nakagama.yu@omu.ac.jp (Y.N.); kaku@omu.ac.jp (N.K.); d21385x@omu.ac.jp (S.N.); e21499e@omu.ac.jp (Y.N.); kakeya@omu.ac.jp (H.K.); kidoyasu@omu.ac.jp (Y.K.) – name: 4 Management Bureau, Osaka Metropolitan University Hospital, Osaka 545-8585, Japan; kyou@omu.ac.jp |
Author_xml | – sequence: 1 givenname: Ayae surname: Nishiyama fullname: Nishiyama, Ayae – sequence: 2 givenname: Takuto orcidid: 0000-0002-6011-9631 surname: Nogimori fullname: Nogimori, Takuto – sequence: 3 givenname: Yuji orcidid: 0000-0003-2349-6320 surname: Masuta fullname: Masuta, Yuji – sequence: 4 givenname: Tomoka surname: Matsuura fullname: Matsuura, Tomoka – sequence: 5 givenname: Tetsuo surname: Kase fullname: Kase, Tetsuo – sequence: 6 givenname: Kyoko orcidid: 0000-0003-1567-0667 surname: Kondo fullname: Kondo, Kyoko – sequence: 7 givenname: Satoko orcidid: 0000-0003-3239-5249 surname: Ohfuji fullname: Ohfuji, Satoko – sequence: 8 givenname: Yu surname: Nakagama fullname: Nakagama, Yu – sequence: 9 givenname: Natsuko surname: Kaku fullname: Kaku, Natsuko – sequence: 10 givenname: Sachie surname: Nakagama fullname: Nakagama, Sachie – sequence: 11 givenname: Yuko surname: Nitahara fullname: Nitahara, Yuko – sequence: 12 givenname: Yoshimasa surname: Takahashi fullname: Takahashi, Yoshimasa – sequence: 13 givenname: Hiroshi orcidid: 0000-0002-6251-1696 surname: Kakeya fullname: Kakeya, Hiroshi – sequence: 14 givenname: Yasutoshi orcidid: 0000-0003-3615-2631 surname: Kido fullname: Kido, Yasutoshi – sequence: 15 givenname: Wakaba surname: Fukushima fullname: Fukushima, Wakaba – sequence: 16 givenname: Takuya orcidid: 0000-0003-3753-1211 surname: Yamamoto fullname: Yamamoto, Takuya |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40006687$$D View this record in MEDLINE/PubMed |
BookMark | eNptks1vFCEYxiemxn7YuydD4sXLVBiGr5PZbLruJjUmrRpvhIV3VjYzsA4za-pfX7Zba7cRDvC-_Hjghee0OAoxQFG8IfiCUoU_bI21PkAiFFeY1PhFcVJhwUuq6I-jJ_Pj4jylNc5NESq5eFUc1zngXIqTYjvtY0rlNRg7-C2gmS0_g_NmAIcmYfDL6G7RNaRNDAkSGiJahKYdIfwxaD5BNwN0eXnlY0A-oPnYmYBuoDdoFts2_vZhlUOTYjAt-n5_YTNk-HXxsjFtgvOH8az4Nrv8Op2XV18-LaaTq9LWNRnK2jqu8r05Z4LVxLCqkYxXuFkSJxhVOWmlqh1zYJXDQjrGRSWopSAMh5qeFYu9rotmrTe970x_q6Px-j4R-5U2_eBtC7qRhFqCicRc1ZV1ikolWSMsW3IKGGetj3utzbjswFkIQ2_aA9HDleB_6lXcakIkx0LJrPD-QaGPv0ZIg-58stC2JkAck6ZE5B8irFYZffcMXcexz6-4pyrKpKD_qJXJFfjQxHyw3YnqiayUUoKI3SNc_IfK3UHnbTZV43P-YMPbp5U-lvjXNhnAe8Du3NND84gQrHfm1M_NSe8AyYfVeg |
ContentType | Journal Article |
Copyright | COPYRIGHT 2025 MDPI AG 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 by the authors. 2025 |
Copyright_xml | – notice: COPYRIGHT 2025 MDPI AG – notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 by the authors. 2025 |
DBID | AAYXX CITATION NPM 3V. 7T7 7XB 8FD 8FE 8FH 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 GNUQQ GUQSH HCIFZ LK8 M2O M7P MBDVC P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/vaccines13020140 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database ProQuest Central Student Research Library Prep SciTech Premium Collection Biological Sciences Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2076-393X |
ExternalDocumentID | oai_doaj_org_article_f813c101806942cd938985f7c5b63e00 PMC11860798 A829997174 40006687 10_3390_vaccines13020140 |
Genre | Journal Article |
GeographicLocations | Japan United States--US |
GeographicLocations_xml | – name: Japan – name: United States--US |
GrantInformation_xml | – fundername: the Ministry of Health, Labour and Welfare, Japan grantid: 20HA2001 – fundername: The Japan Agency for Medical Research and Development grantid: JP23wm0125003 – fundername: Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) grantid: 24K02498 – fundername: Intramural Research Program of the Center for Intractable Diseases and Immunogenomics (CiDIG), National Institutes of Biomedical Innovation, Health, and Nutrition – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP23wm0125003 – fundername: Ministry of Health, Labour, and Welfare, Japan grantid: 20HA2001 |
GroupedDBID | 53G 5VS 8FE 8FH 8G5 AADQD AAHBH AAYXX ABUWG ADBBV AEUYN AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO GNUQQ GROUPED_DOAJ GUQSH HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM 3V. NPM PMFND 7T7 7XB 8FD 8FK C1K FR3 MBDVC P64 PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c441t-4cd690096657541a52f85620fb1d7539754c894d5dec9d078d567273c3e7a6e43 |
IEDL.DBID | M48 |
ISSN | 2076-393X |
IngestDate | Wed Aug 27 01:25:09 EDT 2025 Thu Aug 21 18:27:35 EDT 2025 Fri Jul 11 02:59:51 EDT 2025 Fri Jul 25 11:57:46 EDT 2025 Tue Jun 17 21:59:46 EDT 2025 Tue Jun 10 21:02:11 EDT 2025 Sat Mar 01 01:25:39 EST 2025 Tue Jul 01 01:11:18 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | influenza virus vaccine antibody-dependent cellular cytotoxicity antibody-dependent cellular phagocytosis |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-4cd690096657541a52f85620fb1d7539754c894d5dec9d078d567273c3e7a6e43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-3753-1211 0000-0003-1567-0667 0000-0002-6011-9631 0000-0003-2349-6320 0000-0003-3239-5249 0000-0002-6251-1696 0000-0003-3615-2631 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/vaccines13020140 |
PMID | 40006687 |
PQID | 3171235873 |
PQPubID | 2032320 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f813c101806942cd938985f7c5b63e00 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11860798 proquest_miscellaneous_3171381549 proquest_journals_3171235873 gale_infotracmisc_A829997174 gale_infotracacademiconefile_A829997174 pubmed_primary_40006687 crossref_primary_10_3390_vaccines13020140 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20250128 |
PublicationDateYYYYMMDD | 2025-01-28 |
PublicationDate_xml | – month: 1 year: 2025 text: 20250128 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Vaccines (Basel) |
PublicationTitleAlternate | Vaccines (Basel) |
PublicationYear | 2025 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
SSID | ssj0000913867 |
Score | 2.293083 |
Snippet | Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their... Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness... Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 140 |
SubjectTerms | Antibodies antibody-dependent cellular cytotoxicity antibody-dependent cellular phagocytosis Antigens Avian flu Cloning Control Cross-protection Cytotoxicity Domains Dosage and administration Enzymes Epitopes Evaluation Health aspects Hemagglutinins Immune response Immunization Immunoglobulin G Infections Influenza Influenza A Influenza vaccines influenza virus Influenza viruses Neutralization Pandemics Patient outcomes Peptides Phagocytosis Proteins vaccine Vaccines Viral antibodies Viral infections Viruses |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQbwItMhIqQqrVJLYT-7hUrBakoqq0qDfLsR2xhyaITVstv54ZO91u4MCFwx42diTbM56ZL_Mi5G2hgi1cK5lUTXQzCoY1SJi0Vd2APpZlzOM-_lItzsXnC3mx1eoLY8JSeeB0cIetKriLZaYqLUrnNWhYJdvayabiIY9oHXTeFpiKMlgXXFV18ktywPWH19ahp3qFjjpEFRM9FMv1_y2Ut7TSNGJySwXNH5IHo-1IZ2nNj8i90D0m-yep-PT6gJ7d5VKtDug-PbkrS71-Qq6PcCHsNNgo4ujcsePYpyN4OuuGZdP7NT1NIbNhRYeefkoNTH5ZupjRr0O4hGEMX6bLjsaP_xQkjaVzYKX-BlQg_LXRsqff4jFEoj8l5_OPZ0cLNnZdYA5Mo4EJ5wExA7JBl4worCxbBUZS3jaFB2yj4aFTWnjpg9MeLAwv0ZvLHQ-1rYLgz8hO13fhBaGAlnSZcwdWioOXfNMITNh0IBN4gF9G3t_SwPxIxTUMgBKkl_mTXhn5gETazMOy2PEBMIsZmcX8i1ky8g5JbPDyAh2dHXMQYLlYBsvMFGhnDQhXZGR3MhMunZsO3zKJGS_9yoApFjOPa9jYm80wvomBbF3or9IcMJIAlWfkeeKpzZZENABVnRE14bbJnqcj3fJ7LAkOMLHKa61e_o9TekXul9jlOC9YqXbJzvDzKuyB6TU0r-Mt-w0aiCls priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFH-C7sIFwfgKjMlIaAhp0fJhJ84JddOqgrSpKhvaLXJsZ_RAMpZsqPz1vOek7bJJHHJo7ERO37ef3-8BfAylVaEuhS9k4dKM3CcMEl-oJC3QHovI1XGfnCbTc_7tQlz0G25Nf6xypROdoja1pj3yA7Rzrqwzjb9c_fapaxRlV_sWGo9hC1WwlCPYOjw-nc3XuyyEeimTtMtPxhjfH9wqTRnrhhJ2FF0M7JGD7X-onO9Yp-HJyTumaPIMnvY-JBt3RH8Oj2y1DXuzDoR6uc_ONjVVzT7bY7MNPPXyBdwe0UL8uVVO1bGJ9k9cvw5r2LhqF0VtlmzeHZ21DWtr9rVrZPJXsemYfW_tLxymY8xsUTGXBGCocRSbIEvVf9AU4k_lPHz2w_0Njvgv4XxyfHY09fvuC75GF6n1uTYYOWOEQ6kZHioRlRKdpaAsQoMxToY3tcy4EcbqzKCnYQRldWMd21QllsevYFTVlX0DDKOmLApijd6KxodMUXAq3NSoG2KLlwefVzTIrzqQjRyDE6JXfp9eHhwSkdbzCB7b3aivL_Ne2vJShrF22GRJxiNtMnTLpChTLYoktgG-5BOROCchRjpq1dci4HIJDisfS7TSGUa63IOdwUwUPj0cXjFJ3gt_k29Y1YMP62F6kg60Vba-6eags4TRuQevO55afxJ3jqBMPZADbht883CkWvx00OAYLiZBmsm3_1_XO3gSUR9j2koKdmDUXt_Y9-hctcVuL0H_ABu3I5w priority: 102 providerName: ProQuest |
Title | Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40006687 https://www.proquest.com/docview/3171235873 https://www.proquest.com/docview/3171381549 https://pubmed.ncbi.nlm.nih.gov/PMC11860798 https://doaj.org/article/f813c101806942cd938985f7c5b63e00 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZge-EF8ZvCqIyEhpBmSGI7sR8Q6qZVBalTVVbUtyixHagECbTZoPz13Dlpu8BeeOhDYyeKfWff9-V8d4S8CJXLQlNIJlXu3YyCYQ4SJrM4ycEey8jHcY_P4tFMfJjL-S48up3A1bXUDutJzZZfX__6sX4HC_4tMk6g7G8uM4NO6BX64JAw3CT7YJcSrGcwbsG-35d1yJUvKRsBeWdc83njt7z2IR075dP5_7tpX7Fa3ROVV0zU8A653WJLOmiU4S654cp75HDSJKdeH9HzXazV6oge0skubfX6Prk8wRdhU5f5LZAODRv7Oh7O0kFZL_LKrum0OVLrVrSu6PumwMnvjI4G9GPtvkEzHm-mi5J65wCFnSijQ1C16ieYSPibeeRPP_lp8ErxgMyGp-cnI9ZWZWAGoFPNhLHAqIH5oMtGhJmMCgUgKijy0AL30XDRKC2stM5oCwjESvT2csNdksVO8Idkr6xK95hQYFM6CrgBFGPgJpvnAgM6DewZ3MGvR15tZJB-b5JvpEBaUF7p3_LqkWMU0rYfps32F6rl57RdhWmhQm58zrJYi8hYDXBNySIxMo-5C-AhL1HEKaobyNFkbYwCvC6myUoHCqy3BgYseuSg0xMWpek2b5Qk3eh0ClDNRyYnMLDn22a8Ew-6la66aPoAiALW3iOPGp3aDkl4gKiSHlEdbeuMudtSLr74lOFAI-Mg0erJf8zoU3IrwmLHQcgidUD26uWFewYIrM77ZP_49Gwy7fsvGH2_zP4ADQ0vTw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLdGd4AL4pvAACPBENKiJbGdOAeEurGqZWtVlW7aLSS2Az2QjDXbVP4o_kbec9J2AYnbDjkkdiIn7_m938v7IuSNL03qq1y4QmbWzchdrEHiijSMMtDHIrB53MNR2D_mn0_F6Qb5vcyFwbDKpUy0glqXCv-R74Kes2mdEft49tPFrlHoXV220KjZ4tAsrsBkm38YfAL6vg2C3sF0v-82XQVcBaq_crnSYBECckeXA_dTEeQSQICXZ74G7B7DRSVjroU2KtagQbVAbyVTzERpaDiD594im5yFXtAhm3sHo_Fk9VcHq2zKMKr9oYzF3u5lqtBDPkcHIVozLf1n2wT8qwyuacN2pOY11de7R-42mJV2aya7TzZM8YBsj-ui14sdOl3ncM136DYdr8thLx6Sy31ciDsxqRWttKfcoe0PYjTtFtUsK_WCTupQXTOnVUkHdeOUXyntd-mXyvyAYQybprOCWqcDBQmX0h6wcHkFqhdOU2tR0BP7GSyzPSLHN0KXx6RTlIV5SihYaXHgMQXoSMFNOss4JooqkEXMwOGQ90saJGd1UY8EjCGkV_I3vRyyh0RazcNy3PZCef4taXZ3kkufKVsLLYx5oHQMMFCKPFIiC5nx4CHvkMQJCg2go0qb3AdYLpbfSroSUEEMljV3yFZrJmx21R5eMknSCJt5st4aDnm9GsY7MYCuMOVFPQfAmeCxQ57UPLV6JW6Bp4wcIlvc1nrn9kgx-25LkYN5GnpRLJ_9f12vyO3-dHiUHA1Gh8_JnQB7KHu-G8gt0qnOL8wLAHZV9rLZTZR8vekN_Af6M15N |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVEJcEG9cCiwSFCHVih9re31AKH1ECaVRFNqqN2PvrmkO2KVxW4Wfxq9jZu0kNUjcesghXttae17feF4Ab12hU1fmgR2IzIQZuU09SOwgDaMM7XHgmTruw1E4OOafT4PTNfi9qIWhtMqFTjSKWpWSvpF30c6Zss7I7-ZNWsR4r__p_KdNE6Qo0roYp1GzyIGeX6P7Nvs43ENav_O8_v7R7sBuJgzYEmFAZXOp0DtEFE_hB-6mgZcLBAROnrkKcXyMB6WIuQqUlrFCa6oCilz60tdRGmru433vwHpEXlEH1nf2R-PJ8gsPddwUYVTHRn0_drpXqaRo-YyCheTZtGyhGRnwr2G4YRnbWZs3zGD_Adxv8Cvr1Qz3ENZ08Qi2xnUD7Pk2O1rVc8222RYbr1pjzx_D1S5txJ7o1KhZ1pf2oZkVohXrFdU0K9WcTeq0XT1jVcmG9RCVXykb9NjXSv_AZUqhZtOCmQAEQ22Xsj6yc3mNZhj_psa7YCfmNRjGewLHt0KXp9ApykI_B4YeW-w5vkSkJPEilWWcikYl6iVf48-CDwsaJOd1g48EHSOiV_I3vSzYISItz6PW3OZAefE9aSQ9yYXrS9MXLYy5J1WMkFAEeSSDLPS1gzd5TyROSIEgHWXa1EHgdqkVV9ITiBBi9LK5BZutM1HwZXt5wSRJo3hmyUpMLHizXKYrKZmu0OVlfQ4CtYDHFjyreWr5SNyAUBFZIFrc1nrm9koxPTNtydFVDZ0oFhv_39druIuCm3wZjg5ewD2Pxik7ru2JTehUF5f6JWK8KnvVCBODb7ctv38AZF1igg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-Reactive+Fc-Mediated+Antibody+Responses+to+Influenza+HA+Stem+Region+in+Human+Sera+Following+Seasonal+Vaccination&rft.jtitle=Vaccines+%28Basel%29&rft.au=Nishiyama%2C+Ayae&rft.au=Nogimori%2C+Takuto&rft.au=Masuta%2C+Yuji&rft.au=Matsuura%2C+Tomoka&rft.date=2025-01-28&rft.issn=2076-393X&rft.eissn=2076-393X&rft.volume=13&rft.issue=2&rft.spage=140&rft_id=info:doi/10.3390%2Fvaccines13020140&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_vaccines13020140 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon |